Table 2 |
||||
|
Intracellular bacterial survival (× 104) per 2 × 105 eukaryotic cells |
||||
| Cell line (*Macrophages) |
MOI 10 (1.5 h Infection) |
MOI 100 (1.5 h Infection) |
||
|
|
||||
| E.coli gfp |
E.coli gfp+inv |
E.coli gfp |
E.coli gfp+inv |
|
|
|
||||
| D17 |
0 |
20 |
0 |
320 |
| FLK |
0 |
83 |
2 |
168 |
| HEK293 |
0 |
46 |
15 |
627 |
| TB1 |
0 |
2 |
4 |
345 |
| J774* |
0 |
18 |
19 |
270 |
| RAW* |
0 |
17 |
11 |
317 |
Harms et al. Journal of Immune Based Therapies and Vaccines 2009 7:1 doi:10.1186/1476-8518-7-1 |
||||
